ACADEMIC STAFF
+  Fakulti Teknologi Kejuruteraan Kimia Dan Proses (103)
+  Fakulti Teknologi Kejuruteraan Awam (81)
+  Fakulti Teknologi Kejuruteraan Elektrik Dan Elektronik (94)
+  Fakulti Komputeran (80)
+  Fakulti Teknologi Kejuruteraan Mekanikal Dan Automotif (89)
+  Fakulti Sains Dan Teknologi Industri (75)
+  Fakulti Teknologi Kejuruteraan Pembuatan Dan Mekatronik (64)
+  Fakulti Pengurusan Industri (48)
+  Pusat Bahasa Moden (58)
 

Search by Name Expertise

Home> FTA1000-FAKULTI TEKNOLOGI KEJURUTERAAN KIMIA DAN PROSES

DR. RAJALETCHUMY A/P VELOO KUTTY

Contact No. : 095492362
Gender : FEMALE
Nationality : MALAYSIA
Current Positon : DS51-A-PENSYARAH UNIVERSITI
E-Mail : vrajaletchumy@ump.edu.my
 
ACADEMIC QUALIFICATION
. 2015 : IJAZAH KEDOKTORAN (DOCTORAL DEGREE), NATIONAL UNIVERSITY OF SINGAPORE
. 2010 : IJAZAH SARJANA MUDA (BACHELOR DEGREE), UNIVERSITI MALAYSIA PAHANG
. 2005 : STPM, SMK. ST. GEORGE (A) TAIPING
. 2003 : SPM, SMK BUKIT JANA KAMUNTING, PERAK
 
EXPERTISE
EXPERT AREA MAJOR YEARS OF EXPERTISE LEVEL
ADVANCEMENT OF KNOWLEDGE IN APPLIED SCIENCES AND TECHNOLOGIES (INCLUDING AEROSPACE, NANOTECHNOLOGY, MICROWAVE) NANOMEDICINE
5
SANGAT TINGGI
BIOCOMPATIBLE MATERIALS/BIOMATERIALS SYNTHESIS OF BIOMAERIALS SUCH AS POLYMERS
5
SANGAT TINGGI
CELL THERAPY BREAST CANCER TREATMENT
5
SANGAT TINGGI
DRUG DISCOVERY DRUG FORMULATIONS
4
SANGAT TINGGI
NANOMEDICINE NANOFORMULATIONS FOR CANCER TREATMENT
5
SANGAT TINGGI
OTHER CHEMICAL ENGINEERING N.E.C. Chemical Engineering
2
SEDERHANA
OTHER PHARMACEUTICAL INDUSTRY N.E.C. DRUG DELIVERY SYSTEM
7
SANGAT TINGGI
 
EMPLOYMENT HISTORY
EMPLOYER POST JOIN DATE RESIGN DATE STATUS
Teleflex Medical Sdn Bhd R&D ENGINEER 14/06/2010 04/07/2011 TETAP
   
RESEARCH
NO. TITLE ROLE START DATE END DATE STATUS
1. INVESTIGATION OF THE MOLECULAR INHIBITION MECHANISM AND BINDING ENERGIES BETWEEN PRO-INFLAMMATORY ENZYMES AND IRIDOID COMPOUNDS ISOLATED FROM KELULUT FOR ALLERGY-RELATED SYMPTOMS Member 07-SEP-2021 06-SEP-2024 Sedang Berjalan
2. CHEMICAL PROFILING OF ZIZIPHUS MAURITIANA LEAVES EXTRACT AND STUDY THE STRUCTURE CHARACTERIZATION OF NEW ACTIVE COMPOUNDS WITH ITS PHARMACOLOGICAL ACTIVITIES. Member 15-OCT-2020 14-OCT-2022 Selesai (Tidak Mencapai KPI)
3. Antimicrobial Herbal Foaming Hand Wash Leader 13-JUL-2020 12-JUL-2022 Tamat (Laporan akhir dalam semakan)
4. AN IN-VITRO STUDY OF THE MECHANISM OF TARGETED CO-DELIVERY OF DIAGNOSTIC AND THERAPEUTIC AGENTS INTO TRIPLE NEGATIVE BREAST CANCER Leader 15-OCT-2019 14-OCT-2021 Tamat (Perlu hantar laporan akhir)
5. DEVELOPMENT OF QUERCUS INFECTORIA EXTRACT AS NANOMEDICINE FOR TREATMENT OF BREAST CANCER Leader 15-MAR-2019 14-MAR-2021 Tamat (Laporan akhir dikembalikan dan perlu dihantar semula)
6. ANTI-MIGRATORY AND INCREASED CYTOTOXIC EFFECTS OF NOVEL QUERCUS INFECTORIA DRUG LOADED NANOPARTICLES FOR CANCER TREATMENT Leader 30-DEC-2018 29-MAR-2021 Selesai (Mencapai Sebahagian KPI)
7. FORMULATION, CHARACTERIZATION AND INVIVO EFFICACY OF SILVER-LIPID NANOPARTICLES LOADED WITH CAPSAICIN AND CALCIPOTRIENE FOR THE TREATMENT OF PSORIASIS Member 15-APR-2018 14-JUL-2020 Selesai (Mencapai Semua KPI)
8. Evaluation on the role and regulation of inflammatory cytokines in the synthesis of recombinant protein from mammalian cell lines Member 15-AUG-2017 14-AUG-2019 Selesai (Tidak Mencapai KPI)
9. An In-vitro study of the mechanism of targeted co-delivery of diagnostic and therapeutic agents into Triple Negative Breast Cancer Leader 15-AUG-2017 14-AUG-2019 Selesai (Mencapai Semua KPI)
10. CHEMICAL PROFILING OF PROPOLIS EXTRACT BY DIFFERENT ANALYTICAL TECHNIQUES Member 20-JUN-2017 19-JUN-2019 Selesai (Tidak Mencapai KPI)
11. IDENTIFICATION OF ACTIVE BIOCOMPOUNDS FROM CYMBOPOGAN SP. FOR THE REGULATION OF CHOLESTEROL LEVEL IN BLOOD Member 15-JUN-2017 14-JUN-2019 Tamat (Perlu hantar laporan akhir)
12. Engineered nanoparticles for cancer treatment Leader 01-OCT-2015 30-SEP-2017 Tamat (Tutup Projek)
   
PUBLICATION
TYPE PUBLICATION TARIKH PENERBITAN TYPE OF CONTRIBUTION
REFEREED PUBLICATION
JOURNAL Anti-migratory and increased cytotoxic effects of novel dual drug loaded complex hybrid micelles in triple negative breast cancer cells. 06/05/2015 50% contribution in conceiving hypothesis, perform experiments and write the paper
JOURNAL In vivo and ex vivo proofs of concept that cetuximab conjugated vitamin E TPGS micelles increases efficacy of delivered docetaxel against triple negative breast cancer 06/06/2015 100% CONTRIBUTION IN DESIGNING THE EXPERIMENTS, PERFORME THE EXPERIMENTS, ANALYSE THE DATA AND WRITE MANUSCRIPT
ARTICLE Nanomedicine for Treatment of Triple Negative Breast Cancer 05/05/2014 100% contribution in writing the editorial
JOURNAL Novel theranostic DNA nano-scaffolds for the simultaneous detection and killing of Escherichia coli and Staphylococcus aureus 21/04/2014 50% contribution in design the experiments, performed the experiment,analyze the data, and write the manuscript
JOURNAL Theranostic vitamin E TPGS micelles of transferrin conjugation for targeted co-delivery of docetaxel and ultrabright gold nanoclusters. 20/11/2014 50% contribution in performing experiments and analyzing the data
JOURNAL Cetuximab conjugated vitamin E TPGS micelles for targeted delivery of docetaxel for treatment of triple negative breast cancers. 02/12/2013 100% contribution in design the experiments, performed the experiment,analyze the data, and write the manuscript
JOURNAL Cetuximab conjugated vitamin E TPGS micelles for targeted delivery of docetaxel for treatment of triple negative breast cancers. 02/12/2013 100% contribution in design the experiments, performed the experiment,analyze the data, and write the manuscript
   

For best view, please use Mozilla Firefox, Internet Explorer 7.0 or above with resolution 1024 x 768 pixel.

Copyright 2011 Universiti Malaysia Pahang